Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein 70 (Hsp70) is a highly conserved 70 kDa molecular chaperone that plays a central role in maintaining cellular protein homeostasis (proteostasis). It functions by assisting in the folding of nascent polypeptides, refolding misfolded proteins, and directing terminally damaged proteins toward degradation via the ubiquitin-proteasome system. In many cancers, Hsp70 is significantly overexpressed and can be translocated to the plasma membrane (mHsp70), where it contributes to tumor cell survival, metastasis, and resistance to chemotherapy and radiation. In neurodegenerative conditions, Hsp70 acts protectively by sequestering toxic protein aggregates, such as amyloid-beta and tau, to mitigate neuronal damage.\n\nInterestingly, membrane-bound Hsp70 also serves as a unique tumor-specific marker that can be recognized by the innate immune system, specifically natural killer (NK) cells, making it a target for novel immunotherapies. Pharmacological targeting of Hsp70 involves small molecule inhibitors of its ATPase domain, allosteric modulators, and monoclonal antibodies or peptides designed to engage the immune system against membrane-positive tumor cells. These strategies aim to disrupt the protective mechanisms of cancer cells or enhance the clearance of toxic aggregates in neurodegeneration.
Inhibition of ATPase activity, allosteric modulation of the nucleotide-binding domain, disruption of protein-protein interactions with co-chaperones, inhibition of substrate binding, downregulation of protein expression, and activation of natural killer (NK) cells through membrane-bound epitopes.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein family A member 1A (Hsp70) (Hsp70).